Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors.

× No keyword cloud information.

11 in total

Review 1. Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer.

Authors: Rebecca L Stone; Anil K Sood; Robert L Coleman
Journal: Lancet Oncol Date: 2010-03-10 Impact factor: 41.316

Review 2. VEGF inhibition, hypertension, and renal toxicity.

Authors: Suzanne R Hayman; Nelson Leung; Joseph P Grande; Vesna D Garovic
Journal: Curr Oncol Rep Date: 2012-08 Impact factor: 5.075

Review 3. Bevacizumab-induced hypertension: Clinical presentation and molecular understanding.

Authors: Megan Li; Deanna L Kroetz
Journal: Pharmacol Ther Date: 2017-09-04 Impact factor: 12.310

Review 4. Tyrosine Kinase Inhibitor-Induced Hypertension.

Authors: Megha Agarwal; Nidhi Thareja; Melody Benjamin; Andre Akhondi; George D Mitchell
Journal: Curr Oncol Rep Date: 2018-06-21 Impact factor: 5.075

5. Management of antiangiogenic therapy-induced hypertension.

Authors: Nilka de Jesus-Gonzalez; Emily Robinson; Javid Moslehi; Benjamin D Humphreys
Journal: Hypertension Date: 2012-07-30 Impact factor: 10.190

Review 6. More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds.

Authors: Maria Vergoulidou
Journal: Biomark Insights Date: 2015-10-08

Review 10. Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension.

Authors: Rikke Vilsbøll Milling; Daniela Grimm; Marcus Krüger; Jirka Grosse; Sascha Kopp; Johann Bauer; Manfred Infanger; Markus Wehland
Journal: Int J Mol Sci Date: 2018-10-20 Impact factor: 5.923

Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors.